Clarithromycin
- Product NDC
- 50090-5285
- 11-digit product format
- 500905285
- Labeler code
- 50090
- Product ID
- 50090-5285_32c97be4-06fa-446d-bdad-80064b501dcb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clarithromycin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA065144
- Marketing category
- ANDA
- Marketing start
- 2005-10-18
- Marketing end
- 0000-00-00
- Substance
- CLARITHROMYCIN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Macrolide Antimicrobial [EPC],Macrolides [CS],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5285-0 | 50090528500 | 20 TABLET in 1 BOTTLE (50090-5285-0) | 20 tablet | 2020-10-22 | 0000-00-00 | No | No | Current |